These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31479688)

  • 1. ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis.
    da Silva JLG; Passos DF; Bernardes VM; Leal DBR
    Immunol Lett; 2019 Oct; 214():55-64. PubMed ID: 31479688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
    Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
    Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD73 and adenosine generation in the creation of regulatory microenvironments.
    Regateiro FS; Cobbold SP; Waldmann H
    Clin Exp Immunol; 2013 Jan; 171(1):1-7. PubMed ID: 23199317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints.
    Baghbani E; Noorolyai S; Shanehbandi D; Mokhtarzadeh A; Aghebati-Maleki L; Shahgoli VK; Brunetti O; Rahmani S; Shadbad MA; Baghbanzadeh A; Silvestris N; Baradaran B
    Life Sci; 2021 Oct; 282():119826. PubMed ID: 34265363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenosinergic system: a potential player in the pathogenesis of ANCA-associated vasculitis?
    Kling L; Krämer BK; Yard BA; Kälsch AI
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):143-151. PubMed ID: 29745882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular ATP and adenosine: The Yin and Yang in immune responses?
    Faas MM; Sáez T; de Vos P
    Mol Aspects Med; 2017 Jun; 55():9-19. PubMed ID: 28093236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer.
    Novak I; Yu H; Magni L; Deshar G
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the CD73-adenosine axis in immuno-oncology.
    Allard D; Chrobak P; Allard B; Messaoudi N; Stagg J
    Immunol Lett; 2019 Jan; 205():31-39. PubMed ID: 29758241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor-Mediated Activation of CD39 Internalization in BMDCs Leads to Extracellular ATP Accumulation and Facilitates P2X7 Receptor Activation.
    Zhao R; Qiao J; Zhang X; Zhao Y; Meng X; Sun D; Peng X
    Front Immunol; 2019; 10():2524. PubMed ID: 31736956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the adenosine pathway for cancer immunotherapy.
    Hammami A; Allard D; Allard B; Stagg J
    Semin Immunol; 2019 Apr; 42():101304. PubMed ID: 31604539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer-derived adenosine: new therapeutic approaches.
    Young A; Mittal D; Stagg J; Smyth MJ
    Cancer Discov; 2014 Aug; 4(8):879-88. PubMed ID: 25035124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of purinergic signaling in diabetes: Focus on vascular function.
    Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
    J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD39 and CD73 in immunity and inflammation.
    Antonioli L; Pacher P; Vizi ES; Haskó G
    Trends Mol Med; 2013 Jun; 19(6):355-67. PubMed ID: 23601906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
    Quast C; Alter C; Ding Z; Borg N; Schrader J
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
    Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
    Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity.
    Dorneles GP; Teixeira PC; da Silva IM; Schipper LL; Santana Filho PC; Rodrigues Junior LC; Bonorino C; Peres A; Fonseca SG; Monteiro MC; Boeck CR; Eller S; Oliveira TF; Wendland EM; Romão PRT
    J Cell Physiol; 2022 Aug; 237(8):3394-3407. PubMed ID: 35754396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.